NLRP3 and type 2 diabetes mellitus: Interestingly, NLRP3 inflammasome activation, which leads to inflammatory cytokine release and pyroptosis, has been shown to be involved in immune-related diseases, such as rheumatoid arthritis (RA), type 2 diabetes, atherosclerosis, and asthma (39–41).